BioLoomics
Signal active
Organization
Contact Information
Overview
BioLoomics is a biotechnology company that uses directed evolution to develop antibodies with programmable spatial fate in target cells.
About
Industries
Biotechnology, Health Care, Sensor
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
BioLoomics headquartered in United States, North America, operates in the Biotechnology, Health Care, Sensor sector. The company focuses on Biotechnology and has secured $485.5M in funding across 48 round(s). With a team of 11-50 employees, BioLoomics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - BioLoomics, raised $8.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
9
Lead Investors
0
Total Funding Amount
$10.1M
Details
3
BioLoomics has raised a total of $10.1M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | 600.0K | ||
| 2021 | Seed | 575.0K | ||
| 2023 | Seed | 8.7M |
Investors
BioLoomics is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| BioLoomics | - | FUNDING ROUND - BioLoomics | 8.7M |
| Innovation Endeavors | - | FUNDING ROUND - Innovation Endeavors | 8.7M |
| BioLoomics | - | FUNDING ROUND - BioLoomics | 8.7M |
| BoxOne Ventures | - | FUNDING ROUND - BoxOne Ventures | 8.7M |
Recent Activity
There is no recent news or activity for this profile.